You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 科華生物漲停 新冠病毒檢測產品獲歐盟市場自由銷售證書
格隆匯 03-18 11:18
格隆匯3月18日丨科華生物(002022.SZ)漲停,報15.51元,最新總市值79.8億,現有封單8萬餘手。公司17日收到關於新型冠狀病毒檢測相關產品的歐盟市場自由銷售證書。本次獲得歐盟自由銷售證書的四種新型冠狀病毒檢測試劑,涵蓋了分子診斷與免疫檢測方法學,也包括了適用於有快速診斷需求場合下對全血樣本進行檢測的產品。上述產品取得歐盟自由銷售證書表明公司上述產品符合歐盟醫療器械相關指令的符合性要求,且已完成歐盟主管當局登記註冊,具備歐盟市場的准入資格。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account